Table of Content


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders


2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome


3. Executive Summary
3.1. Market Outlook
3.2. Drug Class Outlook
3.3. Formulation Outlook
3.4. Distribution Channel Outlook
3.5. Competitor Outlook


4. Market Overview
4.1. Introduction


5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges


6. United States Antacids Market, By Drug Class
6.1. Introduction
6.2. Acid Neutralizers
6.3. H2 Antagonist
6.4. Proton Pump Inhibitor


7. United States Antacids Market, By Formulation
7.1. Introduction
7.2. Liquid
7.3. Powder
7.4. Tablet


8. United States Antacids Market, By Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacy
8.3. Retail Pharmacy


9. 360iResearch Competitive Strategic Window
9.1. Introduction
9.2. 360iResearch Competitive Strategic Window, by Drug Class
9.3. 360iResearch Competitive Strategic Window, by Formulation
9.4. 360iResearch Competitive Strategic Window, by Distribution Channel


10. Competitive Landscape
10.1. 360iResearch FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. 360iResearch Market Ranking Analysis
10.3. 360iResearch Market Share Analysis
10.4. 360iResearch Competitive Scenario
10.4.1. Merger & Acquisition
10.4.2. Agreement, Collaboration, & Partnership
10.4.3. New Product Launch & Enhancement
10.4.4. Investment & Funding
10.4.5. Award, Recognition, & Expansion


11. Company Usability Profiles
11.1. GSK
11.2. Johnson & Johnson
11.3. Novartis Consumer Health
11.4. Private Lable
11.5. Wellspring Pharm


12. Appendix
12.1. Discussion Guide
12.2. Edition Details
12.3. License Details
12.4. Pricing Details



List of Figures



FIGURE 1. UNITED STATES ANTACIDS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES ANTACIDS MARKET: RESEARCH EXECUTION
FIGURE 3. UNITED STATES ANTACIDS MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. UNITED STATES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2019 VS 2025 (USD MILLION)
FIGURE 5. UNITED STATES ANTACIDS MARKET SIZE, BY FORMULATION, 2019 VS 2025 (USD MILLION)
FIGURE 6. UNITED STATES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019 VS 2025 (USD MILLION)
FIGURE 7. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES ANTACIDS MARKET, BY TYPE
FIGURE 8. UNITED STATES ANTACIDS MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 9. UNITED STATES ANTACIDS MARKET SIZE GROWTH , 2017-2025 (USD MILLION)
FIGURE 10. UNITED STATES ANTACIDS MARKET: MARKET DYNAMICS
FIGURE 11. UNITED STATES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2019 VS 2025 (USD MILLION)
FIGURE 12. UNITED STATES ANTACIDS MARKET SIZE, BY FORMULATION, 2019 VS 2025 (USD MILLION)
FIGURE 13. UNITED STATES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANTACIDS MARKET SIZE, BY DRUG CLASS, 2025
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANTACIDS MARKET SIZE, BY FORMULATION, 2025
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANTACIDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025
FIGURE 17. UNITED STATES ANTACIDS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 18. UNITED STATES ANTACIDS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS


List of Tables



TABLE 1. UNITED STATES ANTACIDS MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. UNITED STATES ANTACIDS MARKET SIZE, BY ACID NEUTRALIZERS, 2017-2025 (USD MILLION)
TABLE 3. UNITED STATES ANTACIDS MARKET SIZE, BY H2 ANTAGONIST, 2017-2025 (USD MILLION)
TABLE 4. UNITED STATES ANTACIDS MARKET SIZE, BY PROTON PUMP INHIBITOR, 2017-2025 (USD MILLION)
TABLE 5. UNITED STATES ANTACIDS MARKET SIZE, BY LIQUID, 2017-2025 (USD MILLION)
TABLE 6. UNITED STATES ANTACIDS MARKET SIZE, BY POWDER, 2017-2025 (USD MILLION)
TABLE 7. UNITED STATES ANTACIDS MARKET SIZE, BY TABLET, 2017-2025 (USD MILLION)
TABLE 8. UNITED STATES ANTACIDS MARKET SIZE, BY HOSPITAL PHARMACY, 2017-2025 (USD MILLION)
TABLE 9. UNITED STATES ANTACIDS MARKET SIZE, BY RETAIL PHARMACY, 2017-2025 (USD MILLION)
TABLE 10. UNITED STATES ANTACIDS MARKET: SCORES
TABLE 11. UNITED STATES ANTACIDS MARKET: BUSINESS STRATEGY
TABLE 12. UNITED STATES ANTACIDS MARKET: PRODUCT SATISFACTION
TABLE 13. UNITED STATES ANTACIDS MARKET: RANKING
TABLE 14. UNITED STATES ANTACIDS MARKET: MERGER & ACQUISITION
TABLE 15. UNITED STATES ANTACIDS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 16. UNITED STATES ANTACIDS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 17. UNITED STATES ANTACIDS MARKET: INVESTMENT & FUNDING
TABLE 18. UNITED STATES ANTACIDS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 19. UNITED STATES ANTACIDS MARKET: EDITION DETAILS
TABLE 20. UNITED STATES ANTACIDS MARKET: LICENSE DETAILS
TABLE 21. UNITED STATES ANTACIDS MARKET: PRICING DETAILS